ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 63 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 590.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $382,000 | +9.5% | 82,955 | +0.8% | 0.00% | – |
| Q3 2016 | $349,000 | +98.3% | 82,269 | +12.2% | 0.00% | – |
| Q2 2016 | $176,000 | +2.3% | 73,307 | +100.7% | 0.00% | – |
| Q1 2016 | $172,000 | +22.9% | 36,525 | +2.2% | 0.00% | – |
| Q4 2015 | $140,000 | +1.4% | 35,750 | 0.0% | 0.00% | – |
| Q3 2015 | $138,000 | -17.4% | 35,750 | -1.8% | 0.00% | – |
| Q2 2015 | $167,000 | – | 36,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,641,025 | $7,549,000 | 1.29% |
| Squarepoint Ops LLC | 10,200 | $47,000 | 0.02% |
| DELTEC ASSET MANAGEMENT LLC | 15,000 | $69,000 | 0.02% |
| FIRST NEW YORK SECURITIES LLC /NY | 5,700 | $26,220,000 | 0.01% |
| WEDBUSH SECURITIES INC | 11,033 | $51,000 | 0.01% |
| Allen Investment Management, LLC | 15,524 | $71,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,512 | $67,000 | 0.01% |
| A.R.T. Advisors, LLC | 19,216 | $88,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 134,102 | $617,000 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,105 | $79,000 | 0.00% |